00:01
Welcome.
00:02
In this talk, we're
going to cover
various aspects of
alcoholic liver disease.
00:07
This is an umbrella term
that encompasses everything
from alcoholic steatosis
or fatty liver,
which is reversible
entity to steatohepatitis,
which involves inflammation
in association with steatosis,
which can also be reversible.
00:22
And then finally to
end stage cirrhosis,
which is irreversible.
00:27
And all of this is
secondary to alcohol,
misuse or abuse.
00:33
When we talk about
the pathophysiology
of alcoholic liver disease,
we're fundamentally
talking about three stages.
00:39
Starting with a
completely normal liver,
and a little
overindulgence in alcohol
in the vast majority of people
will result in a fatty
liver or steatosis.
00:49
This is reversible,
and with abstinence,
that will revert
completely back to normal.
00:55
In a smaller subset of
patients who develop steatosis
or have recurrent
bouts of steatosis,
related to alcohol intake,
they will develop inflammation.
01:06
In association
with a fatty liver,
which will present
a steatohepatitis,
so there will be inflammation.
01:13
This is also reversible,
and can revert back to a completely
normal liver with abstinence.
01:20
However, in a subset
of those patients,
either due to endogenous
kind of genetic foundations,
or because of recurrent
injury along this pathway,
patients with standard
hepatitis can develop cirrhosis.
01:37
Once you have cirrhosis,
you are at increased risk for
developing hepatocellular carcinoma,
and all the other complications
associated with cirrhosis.
01:46
In addition, a certain
subset of patients
who steatohepatitis
will also develop potentially
hepatocellular carcinoma.
01:56
The epidemiology overall.
01:59
Alcohol use disorder in the
United States is a rampant entity,
maybe 1/5 of the population
is using alcohol to excess.
02:11
It is the second
most common cause
of cirrhosis in
the United States,
only exceeded by non
alcoholic fatty liver disease.
02:20
The presence or the prevalence
of alcoholic fatty liver disease
is about 4% of the
newest population.
02:26
So not everyone
who abuses alcohol
will get alcoholic
fatty liver disease,
but a substantial proportion
of individuals will.
02:35
In alcoholic hepatitis
also develops in a roughly
a third of the alcoholics.
02:42
Risk factors.
02:43
So women tend to have an
increased susceptibility,
this has to do with estrogens
and the metabolism rate
for most women as they
break down alcohol.
02:53
If there is concurrent infection
or other trauma to the liver,
this will increase
the risk of developing
alcohol related steatohepatitis
and or cirrhosis.
03:03
So hepatitis C
concurrent infection
will also increase your risk.
03:09
Obesity and non alcoholic
fatty liver disease
by virtue of giving a
second independent hit
outside of the alcohol toxicity
will also increase
the risk of developing
the other complications
associated with alcohol use.
03:24
A high fat diet,
smoking and diabetes
also because they are
providing additional hits
to the poor unfortunate liver
will also increase the risk
of developing complications.
03:36
In terms of the pathophysiology,
we have to understand
some of the metabolism.
03:41
The main causative factor and
is heavy alcohol consumption.
03:44
And in general, in men, this
is greater than 440 grams a day
or four mixed drinks per day.
03:51
In women, greater
than 20 grams per day,
or two mixed drinks per day.
03:57
To understand what
goes on with alcohol,
you have to understand what
goes on with the metabolism.
04:02
And ingestion of alcohol
is usually degraded in the
liver through the activity
of alcohol dehydrogenase or ADH,
converting it to the intermediate
precursor acetaldehyde.
04:13
There may be a component
involved of catalase activity,
but the ADH pathway
is predominant
and will require the reduction
of an oxidized form of nicotine
adenine dinucleotide or NAD.
04:26
That acetaldehyde is
then rapidly converted
by aldehyde
dehydrogenase to acetate,
which can then
enter the TCA cycle
and be involved in other
intermediary metabolism.
04:37
Again, aldehyde
dehydrogenase requires
the reduction of NAD to NADH.
04:45
That's the normal pathway
and if you have
moderate alcohol intake,
this is more than sufficient
to metabolize all the
alcohol relatively quickly
and efficiently to acetate.
04:56
But with excess alcohol,
But with excess alcohol,
we have involvement I have
a Cytochrome P450 pathway,
which will generate
acetaldehyde again,
but will involve the formation
of reactive oxygen species.
05:11
That acetaldehyde still
has to be further degraded
through aldehyde
dehydrogenase to acetate.
05:17
But that alternate pathway
with the formation of
reactive oxygen species
leads to inflammation,
and in turn will
lead to fibrosis.
05:26
As we are going through
this progressive oxidation
of alcohol to acetaldehyde,
we are using up the
normal reducing capacity
of the hepatic machinery.
05:42
So, we're using up NADs
in order to make acetaldehyde.
05:48
If we do not have adequate NAD,
to then do the other metabolic
functions of the liver,
we will not be able to
metabolize lipids, for example,
and we won't be able to bite
off two carbons from fatty acids
to create acetate,
we will use all of our NAD
to metabolize the alcohol.
06:11
That's why when you
have alcohol excess,
besides the reactive
oxygen species
through the cytochrome
P450. pathway,
you will also not be moving
things fat effectively
through their normal
metabolic pathway.
06:27
So the initial accumulation
is of triglycerides of fat.
06:32
So that initial
step is reversible.
06:36
So we are transiently
using up all of our NADs
to metabolize all that alcohol
and when the alcohol is gone,
then we will turn
back and use the NADs
for lipid metabolism.
06:48
That's how you can go from a
normal liver to a fatty liver
and then revert back
to a normal liver
because we eventually catch up.
06:57
And in the majority of cases
with abstinence that's
exactly what happens.
07:01
However, with recurrent injury,
and or severe
accumulation of fat,
you can actually drive
oxidative damage.
07:11
And this is also going
to be exacerbated
by the cytochrome P450.
07:15
Reactive oxygen species pathway.
07:18
And now we're going to
get steatohepatitis,
to get the fat accumulation
and we'll have inflammation
on top of that.
07:25
Again, if we stop drinking,
then the excess fat goes away.
07:31
The reactive oxygen
species are damped down
by the normal pathways that
tamp those into submission.
07:38
And we can revert all the
way back to a normal liver.
07:41
But with recurrent
bouts of injury,
we can progressively accumulate
damage to hepatocytes
and inflammatory activation,
that exceeds our capacity
to heal, to regenerate,
and to revert and then we get
into irreversible cirrhosis.
08:00
So walking through
the step by step.
08:02
Decreased NAD,
the oxidized form,
impairs our ability
to undergo lipolysis.
08:08
The swollen hepatocytes that
are taking up triglycerides,
we will not be able
to metabolize them,
and we will accumulate that
fat within microvesicles.
08:17
The fat infiltration is
typically close to the venules.
08:21
That's where we have the limiting
amounts of the NAD to begin with.
08:25
And it's being used now
for alcohol metabolism.
08:28
And this can happen
actually overnight,
certainly within two days of
excess alcohol consumption.
08:33
And with abstinence,
it will resolve within
a couple of weeks
after the discontinuation
of alcohol.
08:42
At the hepatitis stage,
there are inflammatory
mediators.
08:45
So Kupffer cells
within the hepatocytes
are feeling the effects
of reactive oxygen species
generated through the
cytochrome P450 system.
08:54
And the effects of excess fat
also potentially driving
additional reactive oxygen species.
09:00
Those Kupffer cells will
generate inflammatory cytokines,
which will recruit and
then activate neutrophils
bringing them in,
especially around
the central area
and a combination of the
reactive oxygen species
and the cytokines from
the inflammatory cells.
09:18
We will get ballooning
degeneration of hepatocytes,
intracellularly because of the
change of the redox potential,
the reduced amount of
NAD that is available,
we will see Mallory bodies which
are just polymerize keratin.
09:34
Cells may eventually die.
09:36
So we may see
hepatocellular necrosis
certainly we will see apoptosis.
09:40
And then as a result
of that activity,
will turn on stellate cells
which are going to be our
precursor cells normally charged
with repopulating the liver,
they're going to turn on.
09:51
Not only they're going to
try to make new hepatocytes
but they're also going to
drive fibrosis or scarring.
09:58
At the end stage or cirrhosis,
those stellate cells have been activated
and laying down a lot of collagen.
10:04
So there's a
perivascular fibrosis.
10:07
And then with continuous
injury by drinking constantly
or by continuous
intermittent bouts of injury,
that injury and regeneration
leads to the stellate cells to
drive hepatocyte regeneration
that is limited by
all of the scarring.
10:26
The damage that's going on,
and particularly the scarring
and the fibrosis is irreversible.
10:32
And now we're going to have
all the secondary consequences
of having an abnormal
scar in the liver
affecting synthetic function,
vascular flow and
bile elimination.
10:44
What's been shown here are
the histologic appearances
of the various stages of
alcoholic liver disease.
10:51
On the left hand side is a normal
H and E stained slide of liver.
10:56
The pink cells are the hepatocytes
in their normal courts.
10:59
The cleared out areas
represent the sinusoids
where blood would be flowing.
11:04
The cells are not showing
lipid accumulation
and there's no inflammation.
11:08
The middle image is
showing you steatosis.
11:11
The individual hepatocytes
are now vacuolated.
11:14
That's literally an
accumulation of triglyceride
because we're not able
to undergo lipolysis
and as we accumulate that
fat, we get clearing.
11:22
Those hepatocytes are alive,
they may not be
particularly happy,
or completely functional,
but they're alive and if
we take away the alcohol,
all this room will revert.
11:33
The panel on the right hand side
is showing steatohepatitis.
11:37
There is more
profound steatosis,
so there's more fat accumulation
and now we're starting
to get an infiltration
of both macrophages or
Kupffer cells and lymphocytes
which are going to
drive the next stage.
11:50
With ongoing injury,
stellate cell activation and the
deposition of extracellular matrix,
we now progress to cirrhosis.
12:01
This is a lower power view
from a biopsy of the liver.
12:05
And the darker pinker material
at the ends of the pointers
is indicating the fibrosis.
12:11
We will get bridging, scarring,
that goes from portal
triad to portal triad,
from portal triad
to central vein
and from central
vein to central vein.
12:20
And this will
criss-cross the liver
and completely encircle what's
left of the normal hepatocytes,
which will be
trying to regenerate
and try to reestablish
a normal liver,
but they're encased
completely surrounded
by scar.
12:36
And grossly,
we can appreciate
this as an irregular
nodular appearance of the liver
with areas of
intervening fibrosis.